Condition
Cervical Cancer (Early Detection)
Total Trials
5
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07351110Not ApplicableRecruiting
Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
NCT07281599Not ApplicableRecruiting
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NCT07606677Not Yet Recruiting
Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women
NCT07345897Not ApplicableRecruiting
Emergency Department-based Cervical Cancer Screening Through Self-sampling
NCT07250841Completed
Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women
Showing all 5 trials